Lately, various therapies such as combination chemotherapy, EGFR tyrosine kinase inhibitors (EGFR-TKI), and angiogenesis inhibitors have become available for brain metastasis originating from lung cancer [13, 14]. Here, EGFR is linked to lung cancer.